Protein phosphorylation profiling of peripheral nerve regeneration after autologous nerve grafting.
Zhangchun ChengYinying ShenTianmei QianSheng YiJianghong HePublished in: Molecular and cellular biochemistry (2020)
Autologous nerve grafting is the golden standard therapeutic approach of peripheral nerve injury. However, the clinical effect of autologous nerve grafting is still unsatisfying. To achieve better clinical functional recovery, it is of an impending need to expand our understanding of the dynamic cellular and molecular changes after nerve transection and autologous nerve transplantation. To address this aim, in the current study, rats were subjected to sciatic nerve transection and autologous nerve grafting. Rat sciatic nerve segments were collected at 4, 7, and 14 days after surgery and subjected to antibody array analysis to determine phosphoprotein profiling patterns. Compared with rats that underwent sham surgery, a total of 48, 19, and 75 differentially expressed phosphoproteins with fold changes > 2 or < -2 were identified at 4, 7, and 14 days after autologous nerve grafting, respectively. Several phosphoproteins, including STAM2 (Phospho-Tyr192) and Tau (Phospho-Ser422), were found to be differentially expressed at multiple time points, suggesting the importance of the phosphorylation of these proteins. Western blot validation of the expression patterns of STAM2 (Phospho-Tyr192) indicated the accuracy of antibody array assay. Bioinformatic analysis of these differentially expressed proteins suggested that cellular behavior and organ morphology were significantly involved biological functions while cell behavior and immune response-related signaling pathways were significantly involved canonical signaling pathways. These outcomes contributed to the illumination of the molecular mechanisms underlying autologous nerve grafting from the phosphoprotein profiling perspective.
Keyphrases
- peripheral nerve
- cell therapy
- bone marrow
- platelet rich plasma
- immune response
- single cell
- signaling pathway
- stem cells
- high throughput
- mesenchymal stem cells
- minimally invasive
- acute coronary syndrome
- epithelial mesenchymal transition
- mass spectrometry
- clinical trial
- breast reconstruction
- adipose tissue
- coronary artery disease
- wound healing